Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway

Nature Chemical Biology

Volumn 12, Issue 4, 2016, Pages 282-289

  Chan, Puiyee ^a   Han, Xiao ^b,c   Zheng, Baohui ^a   Deran, Michael ^a   Yu, Jianzhong ^d   Jarugumilli, Gopala K ^a   Deng, Hua ^d   Pan, Duojia ^d   Luo, Xuelian ^c   Wu, Xu ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b JILIN UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYL GROUP; CYSTEINE; MYOSIN HEAVY CHAIN; PALMITIC ACID; PALMITOYL COENZYME A; TAZ PROTEIN; TEA DOMAIN TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR YAP; UNCLASSIFIED DRUG; 15-HEXADECYNOIC ACID; DNA BINDING PROTEIN; DROSOPHILA PROTEIN; HIPPO PROTEIN, HUMAN; NUCLEAR PROTEIN; PALMITIC ACID DERIVATIVE; PROTEIN BINDING; PROTEIN SERINE THREONINE KINASE; TAZMAN PROTEIN, DROSOPHILA; TEAD1 PROTEIN, HUMAN; TEAD2 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; UNSATURATED FATTY ACID; YORKIE PROTEIN, DROSOPHILA;

ANIMAL TISSUE; ARTICLE; COVALENT BOND; DROSOPHILA; ELECTRON; HUMAN; MOLECULAR WEIGHT; MUSCLE DEVELOPMENT; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; X RAY CRYSTALLOGRAPHY; AMINO ACID SEQUENCE; ANIMAL; CELL DIFFERENTIATION; CELL LINE; CHEMISTRY; CONSERVED SEQUENCE; CYTOLOGY; GENETICS; LIPOYLATION; METABOLISM; MOLECULAR GENETICS; MOLECULAR MODEL; PHYSIOLOGY; PROTEIN TRANSPORT; SEQUENCE ALIGNMENT; SKELETAL MUSCLE CELL;

AMINO ACID SEQUENCE; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CONSERVED SEQUENCE; CYSTEINE; DNA-BINDING PROTEINS; DROSOPHILA PROTEINS; FATTY ACIDS, UNSATURATED; HUMANS; LIPOYLATION; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUSCLE FIBERS, SKELETAL; NUCLEAR PROTEINS; PALMITATES; PROTEIN BINDING; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 84959087365     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.2036     Document Type: Article

References (48)

1. Harvey, K.F., Zhang, X., Thomas, D.M. The Hippo pathway and human cancer. Nat. Rev. Cancer 13, 246-257 (2013).
2. Pan, D. Hippo signaling in organ size control. Genes Dev. 21, 886-897 (2007).
3. Pan, D. The hippo signaling pathway in development and cancer. Dev. Cell 19, 491-505 (2010).
4. Ota, M., Sasaki, H. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development 135, 4059-4069 (2008).
5. Wu, S., Liu, Y., Zheng, Y., Dong, J., Pan, D. The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev. Cell 14, 388-398 (2008).
6. Zhao, B. et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22, 1962-1971 (2008).
7. Zhang, W. et al. VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex. Cell Res. 24, 331-343 (2014).
8. Jiao, S. et al. A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell 25, 166-180 (2014).
9. Johnson, R., Halder, G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat. Rev. Drug Discov. 13, 63-79 (2014).
10. Smotrys, J.E., Linder, M.E. Palmitoylation of intracellular signaling proteins: regulation and function. Annu. Rev. Biochem. 73, 559-587 (2004).
11. Roth, A.F. et al. Global analysis of protein palmitoylation in yeast. Cell 125, 1003-1013 (2006).
12. Wan, J., Roth, A.F., Bailey, A.O., Davis, N.G. Palmitoylated proteins: purification and identification. Nat. Protoc. 2, 1573-1584 (2007).
13. Martin, B.R., Cravatt, B.F. Large-scale profiling of protein palmitoylation in mammalian cells. Nat. Methods 6, 135-138 (2009).
14. Yount, J.S. et al. Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat. Chem. Biol. 6, 610-614 (2010).
15. Resh, M.D. Trafficking and signaling by fatty-acylated and prenylated proteins. Nat. Chem. Biol. 2, 584-590 (2006).
16. Fukata, Y., Fukata, M. Protein palmitoylation in neuronal development and synaptic plasticity. Nat. Rev. Neurosci. 11, 161-175 (2010).
17. Greaves, J., Chamberlain, L.H. DHHC palmitoyl transferases: substrate interactions and (patho)physiology. Trends Biochem. Sci. 36, 245-253 (2011).
18. Kümmel, D., Heinemann, U., Veit, M. Unique self-palmitoylation activity of the transport protein particle component Bet3: a mechanism required for protein stability. Proc. Natl. Acad. Sci. USA 103, 12701-12706 (2006).
19. Duncan, J.A., Gilman, A.G. Autoacylation of G protein alpha subunits. J. Biol. Chem. 271, 23594-23600 (1996).
20. Yang, J. et al. Submicromolar concentrations of palmitoyl-CoA specifically thioesterify cysteine 244 in glyceraldehyde-3-phosphate dehydrogenase inhibiting enzyme activity: a novel mechanism potentially underlying fatty acid induced insulin resistance. Biochemistry 44, 11903-11912 (2005).
21. Resh, M.D. Use of analogs and inhibitors to study the functional significance of protein palmitoylation. Methods 40, 191-197 (2006).
22. Zheng, B. et al. 2-Bromopalmitate analogues as activity-based probes to explore palmitoyl acyltransferases. J. Am. Chem. Soc. 135, 7082-7085 (2013).
23. Zheng, B., Zhu, S., Wu, X. Clickable analogue of cerulenin as chemical probe to explore protein palmitoylation. ACS Chem. Biol. 10, 115-121 (2015).
24. Hannoush, R.N. Profiling cellular myristoylation and palmitoylation using ?-alkynyl fatty acids. Methods Mol. Biol. 800, 85-94 (2012).
25. Hang, H.C., Linder, M.E. Exploring protein lipidation with chemical biology. Chem. Rev. 111, 6341-6358 (2011).
26. Liu-Chittenden, Y. et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 26, 1300-1305 (2012).
27. Tian, W., Yu, J., Tomchick, D.R., Pan, D., Luo, X. Structural and functional analysis of the YAP-binding domain of human TEAD2. Proc. Natl. Acad. Sci. USA 107, 7293-7298 (2010).
28. Jennings, B.C., Linder, M.E. DHHC protein S-acyltransferases use similar ping-pong kinetic mechanisms but display different acyl-CoA specificities. J. Biol. Chem. 287, 7236-7245 (2012).
29. Faergeman, N.J., Knudsen, J. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. Biochem. J. 323, 1-12 (1997).
30. Noland, C.L. et al. Palmitoylation of TEAD transcription factors is required for their stability and function in Hippo pathways. Structure 24, 179-186 (2016).
31. Li, Z. et al. Structural insights into the YAP and TEAD complex. Genes Dev. 24, 235-240 (2010).
32. Chen, L. et al. Structural basis of YAP recognition by TEAD4 in the hippo pathway. Genes Dev. 24, 290-300 (2010).
33. Zhou, Z. et al. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides. FASEB J. 29, 724-732 (2015).
34. Ismail, S.A. et al. Arl2-GTP and Arl3-GTP regulate a GDI-like transport system for farnesylated cargo. Nat. Chem. Biol. 7, 942-949 (2011).
35. Zhang, H. et al. Photoreceptor cGMP phosphodiesterase delta subunit (PDEdelta) functions as a prenyl-binding protein. J. Biol. Chem. 279, 407-413 (2004).
36. Chandra, A. et al. The GDI-like solubilizing factor PDE? sustains the spatial organization and signalling of Ras family proteins. Nat. Cell Biol. 14, 148-158 (2012).
37. Zimmermann, G. et al. Small molecule inhibition of the KRAS PDE? interaction impairs oncogenic KRAS signaling. Nature 497, 638-642 (2013).
38. Dupont, S. et al. Role of YAP/TAZ in mechanotransduction. Nature 474, 179-183 (2011).
39. Nagar, B. et al. Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell 112, 859-871 (2003).
40. Hantschel, O. et al. A myristoyl/phosphotyrosine switch regulates c-Abl. Cell 112, 845-857 (2003).
41. Benhaddou, A. et al. Transcription factor TEAD4 regulates expression of myogenin and the unfolded protein response genes during C2C12 cell differentiation. Cell Death Differ. 19, 220-231 (2012).
42. Yang, Z. et al. Screening with a novel cell-based assay for TAZ activators identifies a compound that enhances myogenesis in C2C12 cells and facilitates muscle repair in a muscle injury model. Mol. Cell. Biol. 34, 1607-1621 (2014).
43. Park, G.H. et al. Novel TAZ modulators enhance myogenic differentiation and muscle regeneration. Br. J. Pharmacol. 171, 4051-4061 (2014).
44. Koontz, L.M. et al. The Hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression. Dev. Cell 25, 388-401 (2013).
45. Turnbull, A.P. et al. Structure of palmitoylated BET3: insights into TRAPP complex assembly and membrane localization. EMBO J. 24, 875-884 (2005).
46. Pobbati, A.V. et al. Targeting the central pocket in human transcription factor TEAD as a potential cancer therapeutic strategy. Structure 23, 2076-2086 (2015).
47. Menendez, J.A., Lupu, R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 7, 763-777 (2007).
48. Sorrentino, G. et al. Metabolic control of YAP and TAZ by the mevalonate pathway. Nat. Cell Biol. 16, 357-366 (2014).